Page 85 - Read Online
P. 85

Hakeem et al. Hepatoma Res 2023;9:38  https://dx.doi.org/10.20517/2394-5079.2023.59  Page 5 of 14

               Inclusion criteria


               ≤ 2 cm tumours with background chronic liver disease.

               Resection is precluded because of underlying liver function or the location of the tumour.


               Biopsy-proven and to exclude patients with mixed hepatocellular/cholangiocellular carcinoma (cHCC-
               CCA).


               No signs of extrahepatic metastatic disease on imaging.

               Good performance status; The Eastern Cooperative Oncology Group (ECOG) 0 or 1.


               Signed, informed consent.


               Exclusion criteria

               Patients with extrahepatic disease or multiple tumours or satellite lesions.


               Patients with previous liver resection for intrahepatic cholangiocarcinoma.

               Patients not fit for LT due to other surgical or anaesthetic reasons.


               Contraindications to liver resection

               The FTWG recognised the importance of providing clear guidelines regarding the contraindications to liver
               resection, which include:


               Patients with advanced liver cirrhosis.

               Patient with inadequate functional liver remnant.


               Inability to obtain a curative intent (R0) resection.

               Presence of extrahepatic disease, lymph node metastases, or multicentric tumours.


               The FTWG expressed concern that the number of patients diagnosed with biopsy-proven iCCA measuring
               ≤ 2 cm would be limited, owing to the difficulties in radiologically diagnosing nodules smaller than 2 cm in
               cirrhotic patients [31-34] . Solitary iCCA > 2-5 cm was discussed as a potential inclusion criterion. In fact, the
               French multicentre study showed that the outcomes in the > 2-5 cm group are comparable to the outcomes
               of  tumours  ≤  2  cm  very  early  iCCA,  but  this  included  patients  with  both  iCCA  (49%)  and
               cHCC-CCA (51%), the latter has shown to have better overall survival outcomes [19,35,36] . According to the
               authors, the use of magnetic resonance imaging (MRI) and increased vigilance in cases where radiographic
               findings are atypical for HCC, combined with advancements in radiological techniques, could lead to a
                                                                    [37]
               higher rate of preoperative diagnosis of iCCA and cHCC-CCA . However, this remains easier for tumours
               up to 5 cm in size and very challenging for tumours smaller than 2 cm. The FTWG concluded that we
   80   81   82   83   84   85   86   87   88   89   90